Transforming diabetes management in cardiology: Impact of novel therapies

Meeting report with video, highlights and slides of a PACE-CME symposium held during ESC 2019 in Paris on Transforming diabetes management in cardiology: Impact of novel therapies.

Recent

Mechanisms of action of GLP-1RAs

10' education - Oct. 21, 2019 - Prof. Filip Knop, MD

GLP-1RA: where do they fit in CV risk management?

10' education - Oct. 21, 2019 - Prof. John Deanfield, MD

The diabetes challenge for cardiologists: The key things to understand

10' education - Sep. 2, 2019 - Prof. Naveed Sattar, MD

Mechanisms of action of GLP-1RAs

10' education - Oct. 21, 2019 - Prof. Filip Knop, MD

GLP-1RA: where do they fit in CV risk management?

10' education - Oct. 21, 2019 - Prof. John Deanfield, MD

The diabetes challenge for cardiologists: The key things to understand

10' education - Sep. 2, 2019 - Prof. Naveed Sattar, MD

Mechanisms of action of GLP-1RAs

10' education - Oct. 21, 2019 - Prof. Filip Knop, MD

Prof. Knop gives an overview of potential mechanisms of action of GLP-1RAs to explain observed effects on glycemia, body weight, blood pressure and blood lipids.

GLP-1RA: where do they fit in CV risk management?

10' education - Oct. 21, 2019 - Prof. John Deanfield, MD

Prof. Deanfield explains why these are exciting times for the management of CVD in patients with diabetes and also in those without diabetes.

The diabetes challenge for cardiologists: The key things to understand

10' education - Sep. 2, 2019 - Prof. Naveed Sattar, MD

Prof. Sattar shows that CV risk is heterogenous in patients with diabetes, and explains why new diabetes drugs, such as GLP-1RAs, are recommended for patients with diabetes and CV risk.

10' Education

Mechanisms of action of GLP-1RAs

10' education - Oct. 21, 2019 - Prof. Filip Knop, MD

GLP-1RA: where do they fit in CV risk management?

10' education - Oct. 21, 2019 - Prof. John Deanfield, MD

The diabetes challenge for cardiologists: The key things to understand

10' education - Sep. 2, 2019 - Prof. Naveed Sattar, MD

Presentation Slides

Slides: 2019 ESC guidelines on diabetes, pre-diabetes and cardiovascular diseases - Expert insights and rationale

Slides (presentation) - Oct. 7, 2019 - Prof Francesco Cosentino, MD, Stockholm, Sweden - CME symposium held during ESC 2019

Slides: The diabetes challenge for cardiologists: The key things to understand

Slides (presentation) - Oct. 7, 2019 - ESC Paris, France - Prof Naveed Sattar, Glasgow, UK

Slides: Mechanisms of action of GLP-1 receptor agonists

Slides (presentation) - Oct. 7, 2019 - ESC Paris, France - Prof. Filip K. Knop, MD PhD, Copenhagen, Denmark - CME symposium held during ESC 2019

Slides: GLP-1RA: where do they fit in CV risk management?

Slides (presentation) - Oct. 7, 2019 - ESC Paris, France - Prof. John E Deanfield, UCL, London, UK - CME symposium held during ESC 2019